Boletín de AInvest
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Jim Cramer praises Kimberly-Clark's CEO Michael Hsu, stating that he's doing a "fantastic job" with the company despite its struggles. Cramer notes that the stock has a 5% yield and is trading at 13 times earnings, making it an "intriguing" investment opportunity. He also discusses the company's planned acquisition of Kenvue, which has been affected by concerns over Tylenol's potential link to autism. Cramer acknowledges the risks but sees the deal as "incredibly compelling."

Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Comentarios
Aún no hay comentarios